Method for repairing intervertebral discs
A method of repairing a defect in an annulus fibrosus of an intervertebral disc, without excising the entire nucleus pulposus of the disc. The method includes inserting an introducer needle through the annulus fibrosus by puncturing the annulus fibrosus with the introducer needle, injecting an in situ curable, bio-compatible polymerizable or polymeric material composition into the disc through the introducer needle directly or indirectly so that the in situ curable composition contacts a defect in the annulus fibrosus; and curing said material in situ.
1. A method of repairing a defect in an annulus fibrosus of an intervertebral disc, without excising the entire nucleus pulposus of the disc, comprising: inserting an introducer needle having a tip through the annulus fibrosus by puncturing the annulus fibrosus with the introducer needle so that the tip of the introducer needle is in the nucleus pulposus, then injecting an in situ curable, bio-compatible polymerizable or polymeric material composition that includes a cross-linking agent into the disc through the introducer needle directly or indirectly so that the in situ curable composition contacts a defect in the annulus fibrosus; and curing said material in situ, wherein the injection of the situ curable, bio-compatible polymerizable or polymeric material composition is performed using an apparatus for percutaneous delivery of a sealant comprising: at least two fluid reservoirs, the introducer needle having a distal tip that is in fluid communication with at least one reservoir, a fluid delivery tube that is in fluid communication with a second reservoir, wherein the fluid delivery tube has a tip and wherein the fluid delivery tube is configured so that the tip of the fluid delivery tube does not extend past the distal tip of the introducer needle during use.
2. A method as claimed in claim 1 wherein said curable material is in flowable liquid form.
3. A method as claimed in claim 1 wherein said curable material comprises a combination of at least two components, and wherein at least one of said components is a cross linkable material and at least one other of said components is a cross linking agent for said cross linkable material.
4. A method as claimed in claim 3 wherein said cross linking agent is a polymeric compound having at least two epoxy groups therein.
5. A method as claimed in claim 3 wherein said cross linking agent is a chemical cross linking agent that is reactive with said cross linkable material.
6. A method as claimed in claim 1 wherein said defect is an opening in said annulus fibrosus that has been caused surgically.
7. A method as claimed in claim 1 wherein said defect is an opening in said annulus fibrosus that has been caused by herniation.
8. A method as claimed in claim 1 wherein said defect is an opening in said annulus fibrosus that has been caused by trauma.
9. A method as claimed in claim 1 wherein said defect is an opening in said annulus fibrosus that has been caused by natural degeneration.
10. A method as claimed in claim 1 wherein said defect is an opening in said annulus fibrosus that has been caused by dehydration or loss of disc height due to dehydration.
11. A method as claimed in claim 1 wherein said curable material comprises at least one polymeric component.
12. A method as claimed in claim 1 wherein said curable material is cured in situ by the action of heat thereon.
13. A method as claimed in claim 1 wherein said curable material is cured in situ by the action of electromagnetic radiation thereon.
14. A method as claimed in claim 1 wherein said curable material is cured in situ by the action of UV light.
15. A method as claimed in claim 1 wherein said cross linkable material comprises a flowable, semi-solid material.
16. A method as claimed in claim 1 wherein said in situ cured material comprises a visco-elastic bio-compatible material that has physical properties that are at least substantially similar to the physical properties of said annulus fibrosus.
17. A method as claimed in claim 1 wherein said in situ curable material comprises a biological material.
18. A method as claimed in claim 1 wherein said in situ cured material is biodegradable over a period of time that is substantially equal to the period of time during which additional annulus fibrosus material grows to an extent sufficient to fill said defect.
19. A method as claimed in claim 1 wherein said in situ curing is accomplished in less than 2 hours.
20. A method as claimed in claim 1 wherein said in situ curing is accomplished in up to about 40 minutes.
21. A method as claimed in claim 1 wherein said in situ curing is accomplished after at least about 2 minutes.
22. A method as claimed in claim 1 wherein said in situ curing is accomplished after at least about 30 seconds.
23. A method as claimed in claim 1 wherein said cured material comprises a hydrogel.
24. A method as claimed in claim 1 wherein said defect in said annulus fibrosus comprises at least one fissure in the annulus fibrosus.
25. A method as claimed in claim 24 wherein said at least one fissure has been caused by disc degeneration.
26. A method according to claim 1 , further comprising a pharmaceutically active agent selected from the group consisting of growth factors, differentiation factors, enzymes, receptor agonists or antagonists, antibodies, hormones, analgesics, local anesthetics, anti-inflammatory drugs, TNF-α inhibitors, anti-microbial agents; antibiotics; antiproliferative, cytotoxic, and antitumor drugs; antiangiogen; antivirals; cytokines; colony stimulating factors; proteins; chemoattractants; EDTA; histamine; antihistamine; erythropoietin; antifungals; antiparasitic agents; non-corticosteroid anti-inflammatory agents; anticoagulants; anesthetics; analgesics; oncology agents; cardiovascular drugs; glycoproteins; fibronectin; peptides; interferons; cartilage inducing factors; protease inhibitors; vasoconstrictors, vasodilators, demineralized bone or bone morphogenetic proteins; hormones; lipids; carbohydrates; proteoglycans, versican, decorin, biglycan; antiangiogenins; antigens; DBM; hyaluronic acid and salts and derivatives thereof; polysaccharides; cellulose compounds; gene therapy reagents; genetically altered cells, stem cells; cell growth factors; type I and II collagen; collagen hydrolysate; elastin; sulfated glycosaminoglycan (sGAG), glucosamine sulfate; pH modifiers; methylsulfonylmethane (MSM); osteogenic compounds; osteoconductive compounds; plasminogen; nucleotides; oligonucleotides; polynucleotides; polymers; cartilage; oxygen-containing components; enzymes; melatonin; vitamins; nutrients, and combinations thereof.
27. A method as claimed in claim 1 , wherein the apparatus for delivering a biocompatible sealant includes at least two reservoirs for fluids to be delivered, an actuation assembly that causes the fluids to flow out of the reservoir through an exit port in the reservoir, and a pressure monitor coupled to the delivery device to measure pressure within the device.